David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 1,562 shares at $67.77 ($106K) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Seasonal sale ($106k) by General Counsel — this insider has traded APLS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.77 | 781 | $53K | 50.0% |
| 2 | $67.77 | 781 | $53K | 50.0% |
| Total | $67.77 avg | 1,562 | $106K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |